Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

Advances in Personalized Oncology

Hiba Mechahougui1, James Gutmans1, Gina Colarusso1

  • 1Oncology Department, Geneva University Hospital (HUG), 1205 Geneva, Switzerland.

Cancers
|August 29, 2024
PubMed

Insights

Next-generation sequencing (NGS) advances precision cancer medicine. Interpreting complex genomic data and selecting targeted therapies requires quality testing and clinical judgment for improved patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Translational Medicine

Background:

  • Next-generation sequencing (NGS) has transformed cancer care towards precision medicine.
  • Targeted therapies and companion diagnostics are key components of this shift.
  • Interpreting extensive genetic mutation data presents a significant clinical challenge.

Purpose of the Study:

  • To highlight the impact of NGS on precision cancer treatment.
  • To discuss the role of targeted therapies and companion diagnostics.
  • To address the challenges in interpreting genomic data for clinical decision-making.

Main Methods:

  • Review of advances in next-generation sequencing technologies.
  • Analysis of the integration of targeted therapies and companion diagnostics.
  • Discussion of clinical decision-making processes for complex genomic profiles.

Main Results:

  • NGS facilitates a move from organ-specific to personalized cancer treatment strategies.
  • Companion diagnostics are crucial for matching therapies to molecular alterations.
  • Quality-centric genomic testing is essential for identifying actionable mutations.

Conclusions:

  • Interpreting complex genomic landscapes is critical for effective cancer therapy selection.
  • Molecular tumor boards can integrate genomic data into clinical trials for refined personalized treatments.
  • Enhanced genomic testing and clinical judgment are vital for improving patient outcomes in precision oncology.
Keywords:
driver mutationsoncogenic alterationsoncogenic driverspersonalized medicineprecision medicineprecision oncology

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K